Myriad Genetics Inc. Stock Charts

MYGN

⊜ Compare

Peers

In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with MYGN

CompareIntrinsic value

NEOGNeogen Corporation

$12.45+2.89%15

LNTHLantheus Holdings, Inc.

$101.14+0.34%92

QDELQuidelOrtho Corporation

$14.35+1.85%0

IDXXIDEXX Laboratories, Inc.

$698.55+3.94%80

COLLCollegium Pharmaceutical Inc.

$23.56-0.72%98

TGTXTG Therapeutics, Inc.

$61.63+1.45%57

RGENRepligen Corporation

$178.20-0.04%35

SUPNSupernus Pharmaceuticals Inc.

$28.21+0.21%44

Held by ETFs

MYGN is in 27 US ETFs. The largest of them, with MYGN's weight in each:

Spot a number that looks wrong? Check it in MYGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MYGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.